CN100355918C - Preparation method and use of single, compound arsenic with bio-effect - Google Patents

Preparation method and use of single, compound arsenic with bio-effect Download PDF

Info

Publication number
CN100355918C
CN100355918C CNB2006100531152A CN200610053115A CN100355918C CN 100355918 C CN100355918 C CN 100355918C CN B2006100531152 A CNB2006100531152 A CN B2006100531152A CN 200610053115 A CN200610053115 A CN 200610053115A CN 100355918 C CN100355918 C CN 100355918C
Authority
CN
China
Prior art keywords
arsenic
biological effect
elemental
arsenide
elemental arsenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100531152A
Other languages
Chinese (zh)
Other versions
CN1912158A (en
Inventor
胡彩虹
徐勇
夏枚生
张红梅
朱兴一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CNB2006100531152A priority Critical patent/CN100355918C/en
Publication of CN1912158A publication Critical patent/CN1912158A/en
Application granted granted Critical
Publication of CN100355918C publication Critical patent/CN100355918C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P10/00Technologies related to metal processing
    • Y02P10/20Recycling

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a method for simple substance arsenic with biology effect and the application. It generates simple substance arsenic by reduction reaction in the colloid system with the existence of protection agent that plays a role of bi-template, dispersing and stabilizing simple substance. The mineral used as carrier supplies large scale surface for the dispersing of simple substance to make it has small diameter, narrow distribution and good stability. The invention has the advantages of low toxicity, high efficiency. It could be used as feed additive or pesticide, and also could be used to make health products and medication for cure tumor.

Description

A kind of elemental arsenic preparation method and purposes with biological effect
Technical field
The present invention relates to a kind of elemental arsenic preparation method and purposes with biological effect.
Background technology
Arsenic belongs to metalloid element, has the character of amphoteric element, and nonmetallic property is stronger.Arsenic is a kind of very dispersive element, seldom sees the arsenic of native state at nature, mainly exists with the sulphide ores form.The toxicity of arsenic compound is relevant with its dissolving poison in water, and element arsenic is water insoluble, thus nontoxic, yellow arsenic, arsenic trisulfide is water-soluble very little, and toxicity is lower, and white arsenic is soluble in water, and toxicity is very big.The toxicity of arsenic compound reduces according to following order: hydrogen arsenide>As 2O 3The compound of>arsenus acid>arsenic acid>arsenic (four arsenic that organic group is positively charged)>elemental arsenic.The toxicity of trivalent arsenic compound is greater than the pentavalent arsenic compound.
Arsenical has antitumor spectra widely, and studying more at present is white arsenic (As 2O 3), yellow arsenic (As 2S 2, the main component of realgar) and organoarsenic U.S.A draw arsenic alcohol (melarsoprol), phenylarsine oxide (PAO) etc.In the arsenical with As 2O 3The toxicity maximum, As is adopted in the antitumor research of carrying out both at home and abroad at present of arsenical more 2O 3(major ingredient is As to arsenic 2O 3) and realgar (major ingredient As 2S 2) as drug use in the traditional Chinese medical science history of existing nearly one thousand years.The traditional Chinese medical science thinks that both are all arduous, poisonous, and Chang Weiliang is used for eliminating dampness, dispels the wind, desinsection and detoxifcation.In western countries, the therapeutic treatment effect of arsenic starts from the 15th century.To 18th century, Thomas doctor Fowler has developed the As that is dissolved in saleratus 2O 3Preparation, Here it is well-known FowlerShi liquid, it mainly is to be used for the treatment of various infectivity and malignant disease by rule of thumb.Chinese scholar adopts injection As in recent years 2O 3Treatment acute promyelocytic leukemia (APL) has been obtained the progress that attracts people's attention, and " science " magazine claims " this is another thrilling discovery after all-trans-retinoic acid (ATRA) ".Thereby the arsenide that always is considered to severe toxicity caused people again, particularly studies the scholars' of tumour pass both at home and abroad, extensively carried out the research of arsenide treatment neoplastic hematologic disorder and solid tumor.But still there are many problems at present in the clinical application of traditional arsenic preparation, and is big as toxic side effect, particle is bigger than normal, bioavailability is lower etc., thus we see contain arsenic class Chinese medicine clinical value in.If can be by improving conventional formulation technology.Adopt modern technologies to prepare and novelly contain arsenic Chinese medicine, will have the important clinical meaning thereby improve bioavailability, reduce drug dose, reduce toxic side effect and improve curative effect.
Arsenic preparation has also obtained using widely in livestock industry.Arsenide as fodder additives mainly is the little organoarsenic of toxicity, and at present commonly used have atoxylic acid (Pro-gen 90), 3-nitro-4-phenol-arsonic acid (Luo Keshasheng), an Arsanilic acid sodium salt etc.Arsenic mainly comprises the biological function of livestock and poultry: 1. participate in protein metabolism; 2. the activator of some enzyme and inhibitor; 3. directly or by the erythrocytic degradation production in the blood come the hemopoietic organ; Can quicken bone growth when low dose of, make the bone hematopoietic function active, impel red corpuscle and hemochrome new life, improve skin-nourishing, the excitor nerve system improves a poor appetite, and improves digestibility; Then suppress hemocytopoietic organ when heavy dose of; 4. prevent arseniasis, arsenic and arsenic all have the anti-toxic unique effect of multiple metal, and each toxic toxinicide each other again, arsenic still are stupid dose of arsenic, mercury, plumbous a word used in person's names; 5. relevant with the breeding of animal; 6. make the attenuation of intestines wall, thereby help the absorption of nutritive substance; 7. reduce intestinal bacteria quantity, have anti-microbial effect, so once once controlled the pig dysentery characterized by blood in the stool with arsenide; 8. can effectively suppress Enterozoa, have outstanding performance aspect the anticoccidial of chicken especially.
Summary of the invention
The purpose of this invention is to provide a kind of elemental arsenic preparation method and purposes with biological effect.
A kind of preparation method with elemental arsenic of biological effect may further comprise the steps:
1) with white arsenic (As 2O 3), arsenic trisulfide (As 2S 3), yellow arsenic (As 2S 2) or the arsenide of their combinations, being dissolved in the aqueous sodium hydroxide solution of 0.1~10moL/L, the solid-to-liquid ratio of arsenide and sodium hydroxide solution is (1~100) g: 1L;
2) with weight be the protective material of 10~1000 times of arsenides, be mixed with the protective material aqueous solution of bulking value concentration for (0.1~100) g: 1L, slowly add in the arsenide aqueous solution of step 1), slowly add the reductive agent that molar ratio is 3~10 times of arsenides down again in stirring, the pH=4 of conditioned reaction system~9, room temperature reaction 1~10 hour;
3) reaction solution step 2) is a kind of elemental arsenic colloidal sol with biological effect, perhaps with step 2) reaction solution that obtains carries out centrifugal or filtering separation under nitrogen or argon gas atmosphere, centrifugal or the filter dehydration in washing back, the filter cake of gained obtains having the elemental arsenic of biological effect being lower than vacuum-drying under 80 ℃ of temperature, being crushed to greater than 300 orders.
The said protective material of the present invention is Xylo-Mucine, glucomannan, chitosan, polyvinyl alcohol, polyoxyethylene glycol or polyvinylpyrrolidone.Said reductive agent is vitamins C, mercaptoethanol, POTASSIUM BOROHYDRIDE, sodium borohydride, Na 2S 2O 3, Na 2S 2O 4, S-WAT, sodium bisulfite, Sodium Pyrosulfite or hydrazine hydrate.
A kind of have the elemental arsenic of biological effect as ox, sheep, livestock and poultry, aquatic animal feed additive.
A kind of elemental arsenic used as pesticides with biological effect.
A kind of elemental arsenic with biological effect is used to prepare by antineoplastic healthcare products of the arsenic of drug treatment and medicine.
Advantage of the present invention is:
(1) the present invention is in the colloidal dispersion that protective material exists, and arsenic compound is added the reductive agent reduction form elemental arsenic.Because protective material absorption is wrapped in the elemental arsenic surface and protective material forms the colloidal dissemination, protective material plays a part template, dispersion and stable elemental arsenic, and the elemental arsenic particle diameter that makes is little, narrowly distributing, good stability.
(2) elemental arsenic of the present invention has low toxicity, characteristics of high efficiency, and use range is extensive, can be used as fodder additives or agricultural chemicals; The arsenic that also can be used for preparing by drug treatment comes antineoplastic healthcare products and medicine.
Embodiment
The present invention is further described in conjunction with following example.
Embodiment 1
1) with white arsenic (As 2O 3) be dissolved in the aqueous sodium hydroxide solution of 0.1moL/L, As 2O 3With the solid-to-liquid ratio of sodium hydroxide solution be 1g: 1L;
2) be As with weight 2O 310 times Xylo-Mucine is mixed with the sodium carboxymethyl cellulose solution that bulking value concentration is 0.1g: 1L, slowly adds the As of step 1) 2O 3In the aqueous solution, slowly adding molar ratio again under stirring is As 2O 33 times vitamins C, the pH=4 of conditioned reaction system, room temperature reaction 1 hour;
3) reaction solution step 2) is a kind of elemental arsenic colloidal sol with biological effect.
Embodiment 2
1) with arsenic trisulfide (As 2S 3) being dissolved in the aqueous sodium hydroxide solution of 10moL/L, the solid-to-liquid ratio of arsenide and sodium hydroxide solution is 100g: 1L;
2) be As with weight 2S 31000 times polyvinylpyrrolidone, being mixed with bulking value concentration is the polyvinylpyrrolidone aqueous solution of 100g: 1L, slowly adds the As of step 1) 2S 3In the aqueous solution, slowly adding molar ratio again under stirring is As 2S 310 times POTASSIUM BOROHYDRIDE, the pH=9 of conditioned reaction system, room temperature reaction 10 hours;
3) with step 2) reaction solution that obtains carries out centrifugation under nitrogen atmosphere, washing back centrifuge dehydration, the filter cake of gained obtains having the elemental arsenic of biological effect being lower than vacuum-drying under 80 ℃ of temperature, being crushed to 400 orders.
Embodiment 3
1) with yellow arsenic (As 2S 2) be dissolved in the aqueous sodium hydroxide solution of 5moL/L, As 2S 2With the solid-to-liquid ratio of sodium hydroxide solution be 50g: 1L;
2) be As with weight 2S 2100 times chitosan, being mixed with bulking value concentration is the chitosan aqueous acetic acid of 10g: 1L, slowly adds the As of step 1) 2S 2In the aqueous solution, slowly adding molar ratio again under stirring is As 2S 27 times hydrazine hydrate, the pH=8.5 of conditioned reaction system, room temperature reaction 5 hours;
3) with step 2) reaction solution that obtains carries out filtering separation under argon gas atmosphere, the dehydration of washing after-filtration, the filter cake of gained obtains having the elemental arsenic of biological effect being lower than vacuum-drying under 80 ℃ of temperature, being crushed to 500 orders.
Embodiment 4
1) with 1 gram white arsenic (As 2O 3) and 1 gram arsenic trisulfide (As 2S 3) arsenide that combines is dissolved in the aqueous sodium hydroxide solution of 200 milliliters of 1moL/L;
2) 100 gram polyvinyl alcohol are dissolved in 10 premium on currency, slowly add again in the arsenide aqueous solution of step 1), slowly add the Na that molar ratio is 10 times of arsenides down again in stirring 2S 2O 3, the pH=6.0 of conditioned reaction system, room temperature reaction 5 hours;
3) reaction solution step 2) is a kind of elemental arsenic colloidal sol with biological effect.

Claims (5)

1. preparation method with elemental arsenic of biological effect is characterized in that the step of method is as follows:
1) with white arsenic (As 2O 3), arsenic trisulfide (As 2S 3), yellow arsenic (As 2S 2) or the arsenide of their combinations, being dissolved in the aqueous sodium hydroxide solution of 0.1~10moL/L, the solid-to-liquid ratio of arsenide and sodium hydroxide solution is (1~100) g: 1L;
2) with weight be the protective material of 10~1000 times of arsenides, be mixed with the protective material aqueous solution of bulking value concentration for (0.1~100) g: 1L, slowly add in the arsenide aqueous solution of step 1), slowly add the reductive agent that molar ratio is 3~10 times of arsenides down again in stirring, the pH=4 of conditioned reaction system~9, room temperature reaction 1~10 hour;
3) reaction solution step 2) is a kind of elemental arsenic colloidal sol with biological effect, perhaps with step 2) reaction solution that obtains carries out centrifugal or filtering separation under nitrogen or argon gas atmosphere, centrifugal or the filter dehydration in washing back, the filter cake of gained is being lower than vacuum-drying under 80 ℃ of temperature, is being crushed to greater than 300 orders, obtain having the elemental arsenic of biological effect
Said protective material is Xylo-Mucine, glucomannan, chitosan, polyvinyl alcohol, polyoxyethylene glycol or polyvinylpyrrolidone.
2. the preparation method with elemental arsenic of biological effect according to claim 1 is characterized in that, said reductive agent is vitamins C, mercaptoethanol, POTASSIUM BOROHYDRIDE, sodium borohydride, Na 2S 2O 3, Na 2S 2O 4, S-WAT, sodium bisulfite, Sodium Pyrosulfite or hydrazine hydrate.
3. the purposes with elemental arsenic of biological effect as claimed in claim 1 is characterized in that it is used as ox, sheep, livestock and poultry, aquatic animal feed additive.
4. purposes with elemental arsenic of biological effect as claimed in claim 1 is characterized in that it uses used as pesticides.
5. the purposes with elemental arsenic of biological effect as claimed in claim 1 is characterized in that being used to prepare by antineoplastic healthcare products of the arsenic of drug treatment and medicine.
CNB2006100531152A 2006-08-24 2006-08-24 Preparation method and use of single, compound arsenic with bio-effect Expired - Fee Related CN100355918C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100531152A CN100355918C (en) 2006-08-24 2006-08-24 Preparation method and use of single, compound arsenic with bio-effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100531152A CN100355918C (en) 2006-08-24 2006-08-24 Preparation method and use of single, compound arsenic with bio-effect

Publications (2)

Publication Number Publication Date
CN1912158A CN1912158A (en) 2007-02-14
CN100355918C true CN100355918C (en) 2007-12-19

Family

ID=37721212

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100531152A Expired - Fee Related CN100355918C (en) 2006-08-24 2006-08-24 Preparation method and use of single, compound arsenic with bio-effect

Country Status (1)

Country Link
CN (1) CN100355918C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111519044A (en) * 2020-05-19 2020-08-11 福州大学 Method for preparing simple substance arsenic by chemical reduction of sodium arsenate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB248975A (en) * 1925-06-10 1926-03-18 Basf Ag Improvements in the manufacture and production of arsenic preparations
US4244927A (en) * 1979-07-27 1981-01-13 Hazen Research, Inc. Process for recovering arsenic compounds by sodium hydroxide leaching
CN1120018A (en) * 1994-05-07 1996-04-10 湖南大学 Method of wet-extraction for arsenic
CN1042919C (en) * 1994-05-07 1999-04-14 湖南大学 Method of wet-extraction for arsenic

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB248975A (en) * 1925-06-10 1926-03-18 Basf Ag Improvements in the manufacture and production of arsenic preparations
US4244927A (en) * 1979-07-27 1981-01-13 Hazen Research, Inc. Process for recovering arsenic compounds by sodium hydroxide leaching
CN1120018A (en) * 1994-05-07 1996-04-10 湖南大学 Method of wet-extraction for arsenic
CN1042919C (en) * 1994-05-07 1999-04-14 湖南大学 Method of wet-extraction for arsenic

Also Published As

Publication number Publication date
CN1912158A (en) 2007-02-14

Similar Documents

Publication Publication Date Title
CN102550836B (en) Animal nutrition additive trace element is combined bag and its preparation method and application
HUE031907T2 (en) Formulations containing triazinones and iron
CN102524540A (en) Saving trace element compound packet as well as preparation method and application thereof
WO2019242044A1 (en) Use of composite nanoparticle of carbon and copper
GB2037306A (en) Cyclodextrin-camomile inclusion complexes and pharmaceutical compositions containing them
CN110692821B (en) Feed additive for improving rumen fermentation efficiency of cattle
CN101491497A (en) Toltrazuril suspension preparation capable of being effectively uniformly dispersed in water and preparation method thereof
CN1947699A (en) Method for producing water soluble fluorophenylnico
CN100355918C (en) Preparation method and use of single, compound arsenic with bio-effect
CN101982176A (en) Compound sodium selenite-vitamin E oral nano-emulsion preparation for livestock and preparation method thereof
RU2281763C1 (en) Method for prophylaxis of sterility in cows
CN110664773A (en) Effervescent tablet for supplementing vitamin C and preventing liver and gallbladder diseases for aquatic animals and preparation method thereof
CN108853024B (en) Colistin sulfate soluble powder and preparation method thereof
CN103749980B (en) Improved-type Selenium supplement agent of intestinal mucosa and its production and use
CN105558435A (en) Feed additive for preventing and treating silver carp hemorrhagic disease
CN100406595C (en) Preparation method and use of bioactive sing-compound arsenic
CN108451903B (en) A kind of Betagen Solution and preparation method thereof
Yazdani et al. Dietary green-synthesized curcumin-mediated zinc oxide nanoparticles promote growth performance, haemato-biochemical profile, antioxidant status, immunity, and carcass quality in Nile tilapia (Oreochromis niloticus)
CN111887249A (en) Environment-friendly nontoxic rodenticide
Boamah et al. Application of low molecular weight chitosan in animal nutrition, husbandry, and health: A Review
CN110183548A (en) A kind of preparation method and applications of low molecular weight dextran iron
CN109276720A (en) A kind of metal-organic complex nano material and its preparation method and application
Aminullah et al. Nano copper in poultry nutrition: potential effects and future prospects-a review
CN115715763B (en) Bromhexine hydrochloride solid microsphere and preparation method thereof
CN116622092A (en) Polysaccharide copper, polysaccharide copper gel, and preparation methods and applications thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20071219

Termination date: 20100824